| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $103.5M | -33.8% |
| Cost of Revenue | $486K | -84.4% |
| R&D Expense | $155.5M | -33.7% |
| SG&A Expense | $71.9M | -8.7% |
| Operating Income | -$120.5M | +24.5% |
| Income Tax | $0 | — |
| Net Income | -$232.3M | +9.8% |
| EPS (Basic) | -$10.59 | -1434.8% |
| EPS (Diluted) | -$10.59 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.4M | -46.9% |
| Accounts Receivable | $407K | -98.4% |
| Current Assets | $45.6M | -59.5% |
| Total Assets | $226.3M | -27.9% |
| Current Liabilities | $221.4M | -13.5% |
| Long-term Debt | $33.2M | +159.8% |
| Stockholders' Equity | -$326.4M | -103.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$158.3M | +29.4% |
| Capital Expenditures | $576K | -94.2% |
| Investing Cash Flow | $27K | -99.2% |
| Financing Cash Flow | $122.8M | +2.5% |
| Free Cash Flow | -$158.9M | +32.1% |
| -1434.8% |